Sensing cells and tissues in disease models: Exploring forces with Cell-Mimicking Beads
November 14th at 6 p.m. (CET) Dr Salvatore Girardo, Max Planck Institute in conversation with Lea Ud…
FLAMIN-GO
From pathobiology to synovia on chip: driving rheumatoid arthritis to the precision medicine goal
WELCOME
FLAMIN-GO’s Vision
FLAMIN-GO’s VISION is to provide an organ-on-chip solution to open up a new avenue towards personalized care in RA. This solution will be based on the design and fabrication a multi-compartment microfluidic platform, for 3D culturing and perfusion, of all the disease-relevant joint tissues, focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system (vessels and leukocytes) who sustain the disease, as well as cartilage and bone which are the end damaged tissues, leading to permanent disability. The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.
Rheumatoid Arthritis? Chip it!
News
Science for all, present it so everyone will listen
November 16th at 3 p.m. (CET) Zoom: https://us06web.zoom.us/j/88922457788 Arijana Filipić, PhD, Arij…
Popular Science Writing
November 13th at 3 p.m. (CET) Zoom: https://us06web.zoom.us/j/88922457788 Prof. Saša Novak, PhD, Sci…
Lab on Chip and Point of Care: from idea to production
November 7th at 6 p.m. Laura Boschis, Trustech Srl, Italy in conversation with Lea Udovč, Slovenian …
Contest: AI-ARThritis Visualizing Rheumatoid Arthritis by Artificial Intelligence
Online contest for AI-created images that are related to Rheumatoid Arthritis
Personalized
Organ-on-chip, a multi-compartment microfluidic platform offering tailoring and personalized treatment solutions.
Targeted
Focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system who sustain the disease, as well as cartilage and bone
Monitoring
The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.